Literature DB >> 14734766

Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.

Amy C Morrison1, Caleph B Wilson, Manujendra Ray, Pamela H Correll.   

Abstract

IL-12, produced by APCs during the initial stages of an immune response, plays a pivotal role in the induction of IFN-gamma by NK and gammadeltaT cells and in driving the differentiation of Th1 cells, thus providing a critical link between innate and acquired immunity. Due to the unique position occupied by IL-12 in the regulation of immunity, many mechanisms have evolved to modulate IL-12 production. We have shown previously that macrophage-stimulating protein (MSP), the ligand for the stem cell-derived tyrosine kinase/recepteur d'origine nantais (RON) receptor, inhibits NO production by macrophages in response to IFN-gamma and enhances the expression of arginase. Mice lacking RON exhibit increased inflammation in a delayed-type hypersensitivity reaction and increased susceptibility to endotoxic shock. In this study we demonstrate that pretreatment of macrophages with MSP before IFN-gamma and LPS results in the complete inhibition of IL-12 production due to suppression of p40 expression. This response is mediated by the RON receptor, and splenocytes from RON(-/-) animals produce increased levels of IFN-gamma. MSP pretreatment of macrophages resulted in decreased tyrosine phosphorylation of Stat-1 and decreased expression of IFN consensus sequence binding protein in response to inflammatory cytokines. In addition to IL-12, the expression of IL-15 and IL-18, cytokines that are also dependent on IFN consensus sequence binding protein activation, is inhibited by pretreatment with MSP before IFN-gamma and LPS. We also show that the ability of MSP to inhibit IL-12 production is independent of IL-10. Taken together, these results suggest that MSP may actively suppress cell-mediated immune responses through its ability to down-regulate IL-12 production and thus inhibit classical activation of macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734766     DOI: 10.4049/jimmunol.172.3.1825

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Role of STK in mouse liver macrophage and endothelial cell responsiveness during acute endotoxemia.

Authors:  Debra L Laskin; Li Chen; Pamela A Hankey; Jeffrey D Laskin
Journal:  J Leukoc Biol       Date:  2010-05-07       Impact factor: 4.962

2.  Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein.

Authors:  Manujendra Ray; Shan Yu; Daniel R Sharda; Caleph B Wilson; QingPing Liu; Naveen Kaushal; K Sandeep Prabhu; Pamela A Hankey
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

3.  Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase.

Authors:  Daniel R Sharda; Shan Yu; Manujendra Ray; Mario Leonardo Squadrito; Michele De Palma; Thomas A Wynn; Sidney M Morris; Pamela A Hankey
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

4.  Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET.

Authors:  Amitabha Chaudhuri; Ming-Hong Xie; Becky Yang; Kaushiki Mahapatra; Jinfeng Liu; Scot Marsters; Sweta Bodepudi; Avi Ashkenazi
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

Review 5.  Progress in tumor-associated macrophage (TAM)-targeted therapeutics.

Authors:  Chayanon Ngambenjawong; Heather H Gustafson; Suzie H Pun
Journal:  Adv Drug Deliv Rev       Date:  2017-04-25       Impact factor: 15.470

6.  Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling.

Authors:  Salim Merali; Carlos A Barrero; Russell P Bowler; Diane Er Chen; Gerard Criner; Alan Braverman; Samuel Litwin; Anthony Yeung; Steven G Kelsen
Journal:  COPD       Date:  2013-10-10       Impact factor: 2.409

7.  Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis.

Authors:  P Goyette; C Lefebvre; A Ng; S R Brant; J H Cho; R H Duerr; M S Silverberg; K D Taylor; A Latiano; G Aumais; C Deslandres; G Jobin; V Annese; M J Daly; R J Xavier; J D Rioux
Journal:  Mucosal Immunol       Date:  2008-01-16       Impact factor: 7.313

8.  RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Authors:  Daniele C Cary; Janice E Clements; Andrew J Henderson
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

9.  Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.

Authors:  Wei Dai; Hong Zheng; Arthur Kwok Leung Cheung; Clara Sze-man Tang; Josephine Mun Yee Ko; Bonnie Wing Yan Wong; Merrin Man Long Leong; Pak Chung Sham; Florence Cheung; Dora Lai-Wan Kwong; Roger Kai Cheong Ngan; Wai Tong Ng; Chun Chung Yau; Jianji Pan; Xun Peng; Stewart Tung; Zengfeng Zhang; Mingfang Ji; Alan Kwok-Shing Chiang; Anne Wing-Mui Lee; Victor Ho-Fun Lee; Ka-On Lam; Kwok Hung Au; Hoi Ching Cheng; Harry Ho-Yin Yiu; Maria Li Lung
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

10.  Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.

Authors:  Henok Eyob; Huseyin Atakan Ekiz; Yoko S Derose; Susan E Waltz; Matthew A Williams; Alana L Welm
Journal:  Cancer Discov       Date:  2013-04-23       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.